Exact Sciences Corp (EXAS)
58.81
+0.02
(+0.03%)
USD |
NASDAQ |
Apr 26, 16:00
58.81
0.00 (0.00%)
After-Hours: 20:00
Exact Sciences Free Cash Flow: 31.93M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 31.93M |
| September 30, 2023 | -23.54M |
| June 30, 2023 | -108.27M |
| March 31, 2023 | -298.22M |
| December 31, 2022 | -438.02M |
| September 30, 2022 | -501.15M |
| June 30, 2022 | -495.23M |
| March 31, 2022 | -355.23M |
| December 31, 2021 | -238.00M |
| September 30, 2021 | -59.34M |
| June 30, 2021 | 87.95M |
| March 31, 2021 | 44.13M |
| December 31, 2020 | 71.40M |
| September 30, 2020 | -90.28M |
| June 30, 2020 | -238.59M |
| March 31, 2020 | -262.37M |
| December 31, 2019 | -284.31M |
| September 30, 2019 | -270.15M |
| June 30, 2019 | -247.16M |
| March 31, 2019 | -249.93M |
| December 31, 2018 | -219.03M |
| September 30, 2018 | -203.24M |
| June 30, 2018 | -166.82M |
| March 31, 2018 | -158.42M |
| December 31, 2017 | -140.89M |
| Date | Value |
|---|---|
| September 30, 2017 | -133.68M |
| June 30, 2017 | -143.13M |
| March 31, 2017 | -136.56M |
| December 31, 2016 | -144.92M |
| September 30, 2016 | -153.35M |
| June 30, 2016 | -163.96M |
| March 31, 2016 | -163.03M |
| December 31, 2015 | -156.00M |
| September 30, 2015 | -151.68M |
| June 30, 2015 | -133.80M |
| March 31, 2015 | -114.04M |
| December 31, 2014 | -93.45M |
| September 30, 2014 | -74.17M |
| June 30, 2014 | -61.17M |
| March 31, 2014 | -53.64M |
| December 31, 2013 | -49.03M |
| September 30, 2013 | -45.20M |
| June 30, 2013 | -44.94M |
| March 31, 2013 | -46.30M |
| December 31, 2012 | -45.20M |
| September 30, 2012 | -43.72M |
| June 30, 2012 | -41.63M |
| March 31, 2012 | -35.28M |
| December 31, 2011 | -29.58M |
| September 30, 2011 | -24.55M |
Free Cash Flow Range, Past 5 Years
-501.15M
Minimum
Sep 2022
87.95M
Maximum
Jun 2021
-193.39M
Average
-238.59M
Median
Jun 2020
Free Cash Flow Benchmarks
| Illumina Inc | 282.00M |
| Guardant Health Inc | -345.46M |
| Natera Inc | -286.15M |
| Quest Diagnostics Inc | 947.00M |
| Castle Biosciences Inc | -19.25M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 69.55M |
| Cash from Investing (Quarterly) | -66.77M |
| Cash from Financing (Quarterly) | 10.04M |
| Free Cash Flow Per Share (Quarterly) | 0.1912 |
| Free Cash Flow to Equity (Quarterly) | 33.27M |
| Free Cash Flow to Firm (Quarterly) | 42.40M |
| Free Cash Flow Yield | 0.30% |